XML 262 R60.htm IDEA: XBRL DOCUMENT
v3.25.0.1

Revenue (Revenue Disaggregation by Geographical Region and Revenue Type) (Details) - USD ($) $ in Millions | 12 Months Ended
--- | ---
Dec. 31, 2024 | Dec. 31, 2023 | Dec. 31, 2022
Disaggregation of Revenue [Line Items] |  |  |
Sales | $ 23,875 | $ 23,890 | $ 26,643
North America |  |  |
Disaggregation of Revenue [Line Items] |  |  |
Sales | 10,295 | 9,961 | 11,730
Western Europe |  |  |
Disaggregation of Revenue [Line Items] |  |  |
Sales | 5,457 | 5,468 | 5,859
Other developed markets |  |  |
Disaggregation of Revenue [Line Items] |  |  |
Sales | 1,253 | 1,270 | 1,345
High-growth markets |  |  |
Disaggregation of Revenue [Line Items] |  |  |
Sales | 6,870 | 7,191 | 7,709
Recurring |  |  |
Disaggregation of Revenue [Line Items] |  |  |
Sales | 19,366 | 18,682 | 20,876
Nonrecurring |  |  |
Disaggregation of Revenue [Line Items] |  |  |
Sales | 4,509 | 5,208 | 5,767
Operating segments | Biotechnology |  |  |
Disaggregation of Revenue [Line Items] |  |  |
Sales | 6,759 | 7,172 | 8,758
Operating segments | Biotechnology | North America |  |  |
Disaggregation of Revenue [Line Items] |  |  |
Sales | 2,237 | 2,454 | 3,054
Operating segments | Biotechnology | Western Europe |  |  |
Disaggregation of Revenue [Line Items] |  |  |
Sales | 2,296 | 2,407 | 2,645
Operating segments | Biotechnology | Other developed markets |  |  |
Disaggregation of Revenue [Line Items] |  |  |
Sales | 335 | 329 | 358
Operating segments | Biotechnology | High-growth markets |  |  |
Disaggregation of Revenue [Line Items] |  |  |
Sales | 1,891 | 1,982 | 2,701
Operating segments | Biotechnology | Recurring |  |  |
Disaggregation of Revenue [Line Items] |  |  |
Sales | 5,758 | 5,897 | 6,958
Operating segments | Biotechnology | Nonrecurring |  |  |
Disaggregation of Revenue [Line Items] |  |  |
Sales | 1,001 | 1,275 | 1,800
Operating segments | Life Sciences |  |  |
Disaggregation of Revenue [Line Items] |  |  |
Sales | 7,329 | 7,141 | 7,036
Operating segments | Life Sciences | North America |  |  |
Disaggregation of Revenue [Line Items] |  |  |
Sales | 3,199 | 2,999 | 3,154
Operating segments | Life Sciences | Western Europe |  |  |
Disaggregation of Revenue [Line Items] |  |  |
Sales | 1,574 | 1,519 | 1,377
Operating segments | Life Sciences | Other developed markets |  |  |
Disaggregation of Revenue [Line Items] |  |  |
Sales | 510 | 510 | 506
Operating segments | Life Sciences | High-growth markets |  |  |
Disaggregation of Revenue [Line Items] |  |  |
Sales | 2,046 | 2,113 | 1,999
Operating segments | Life Sciences | Recurring |  |  |
Disaggregation of Revenue [Line Items] |  |  |
Sales | 4,889 | 4,360 | 4,220
Operating segments | Life Sciences | Nonrecurring |  |  |
Disaggregation of Revenue [Line Items] |  |  |
Sales | 2,440 | 2,781 | 2,816
Operating segments | Diagnostics |  |  |
Disaggregation of Revenue [Line Items] |  |  |
Sales | 9,787 | 9,577 | 10,849
Operating segments | Diagnostics | North America |  |  |
Disaggregation of Revenue [Line Items] |  |  |
Sales | 4,859 | 4,508 | 5,522
Operating segments | Diagnostics | Western Europe |  |  |
Disaggregation of Revenue [Line Items] |  |  |
Sales | 1,587 | 1,542 | 1,837
Operating segments | Diagnostics | Other developed markets |  |  |
Disaggregation of Revenue [Line Items] |  |  |
Sales | 408 | 431 | 481
Operating segments | Diagnostics | High-growth markets |  |  |
Disaggregation of Revenue [Line Items] |  |  |
Sales | 2,933 | 3,096 | 3,009
Operating segments | Diagnostics | Recurring |  |  |
Disaggregation of Revenue [Line Items] |  |  |
Sales | 8,719 | 8,425 | 9,698
Operating segments | Diagnostics | Nonrecurring |  |  |
Disaggregation of Revenue [Line Items] |  |  |
Sales | $ 1,068 | $ 1,152 | $ 1,151

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 91 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91 Reference 3: http://www.xbrl.org/2003/role/exampleRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 91 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91 Reference 4: http://www.xbrl.org/2003/role/exampleRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 91 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91 Reference 5: http://www.xbrl.org/2003/role/exampleRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 91 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91 Reference 6: http://www.xbrl.org/2003/role/exampleRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 91 -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91 Reference 7: http://www.xbrl.org/2003/role/exampleRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 91 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91 Reference 8: http://www.xbrl.org/2003/role/exampleRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 91 -Subparagraph (g) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479777/606-10-55-91 + Details
Name: | us-gaap_DisaggregationOfRevenueLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 41 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 270 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (ee) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32 Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32 Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 924 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SAB Topic 11.L) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 30 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 42 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 22 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 40 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 22 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4 + Details
Name: | us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | srt_StatementGeographicalAxis=srt_NorthAmericaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementGeographicalAxis=dhr_WesternEuropeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementGeographicalAxis=dhr_OtherDevelopedMarketsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementGeographicalAxis=dhr_HighGrowthMarketsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=dhr_RevenuefromContractwithCustomerMeasurementRecurringMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ProductOrServiceAxis=dhr_RevenuefromContractwithCustomerMeasurementNonrecurringMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=dhr_BiotechnologyMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=dhr_LifeSciencesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementBusinessSegmentsAxis=dhr_DiagnosticsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |